VIEW IN BROWSER | SUBSCRIBE WED, NOV 13, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning and happy Wednesday! AstraZeneca said it is doubling down on its investment in its U.S. business, a move that comes just one week after Donald Trump's election win . AstraZeneca announced plans for $2 billion in new spending on research and development, bringing its total capital investment in the country to $3.5 billion by the end of 2026. The cash will be used to boost the company's research and development, as well as its manufacturing footprint in the U.S. The British-Swedish pharmaceutical giant expects the new investment to create more than 1,000 jobs, "contributing to the growth of the U.S. economy," according to a release. The company said it currently has 17,800 U.S. employees working across 17 sites in 12 states. AstraZeneca said the expanded footprint will incl